Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

539 ARTÍCULOS , VIENDO DEL 91 AL 105

Stroke occurring in patients with cognitive impairment or dementia

Moulin S, Leys D.

Arq Neuropsiquiatr. 2017 Feb;75(2):117-121. doi: 10.1590/0004-282X20160187.

DTI measurements for Alzheimer's classification

Maggipinto T, Bellotti R, Amoroso N, Diacono D, Donvito G, Lella E, Monaco A, Antonella Scelsi M, Tangaro S.

Phys Med Biol. 2017 Mar 21;62(6):2361-2375. doi: 10.1088/1361-6560/aa5dbe. Epub 2017 Feb 24.

Observing conversational laughter in frontotemporal dementia

Pressman PS, Simpson M, Gola K, Shdo SM, Spinelli EG, Miller BL, Gorno-Tempini ML, Rankin K, Levenson RW.

J Neurol Neurosurg Psychiatry. 2017 May;88(5):418-424. doi: 10.1136/jnnp-2016-314931. Epub 2017 Feb 24.

Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease

Jia J, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y.

Alzheimers Dement. 2017 May;13(5):592-597. doi: 10.1016/j.jalz.2017.01.007. Epub 2017 Feb 24.

Measurement of Functional Cognition and Complex Everyday Activities in Older Adults with Mild Cognitive Impairment and Mild Dementia: Validity of the Large Allen's Cognitive Level Screen

Wesson J, Clemson L, Crawford JD, Kochan NA, Brodaty H, Reppermund S.

Am J Geriatr Psychiatry. 2017 May;25(5):471-482. doi: 10.1016/j.jagp.2016.11.021. Epub 2017 Jan 4.

Complementary medicine for treatment of agitation and delirium in older persons: a systematic review and narrative synthesis

Levy I, Attias S, Ben-Arye E, Bloch B, Schiff E.

Int J Geriatr Psychiatry. 2017 May;32(5):492-508. doi: 10.1002/gps.4685. Epub 2017 Feb 26.

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh TV, Davis AA, Ulrich JD, Holtzman DM.

J Lipid Res. 2017 May;58(5):824-836. doi: 10.1194/jlr.R075481. Epub 2017 Feb 27.

Effects of pioglitazone on the incidence of dementia in patients with diabetes

Chou PS, Ho BL, Yang YH.

J Diabetes Complications. 2017 Jun;31(6):1053-1057. doi: 10.1016/j.jdiacomp.2017.01.006. Epub 2017 Jan 20.

Effectiveness of person-centered care on people with dementia: a systematic review and meta-analysis

Kim SK, Park M.

Clin Interv Aging. 2017 Feb 17;12:381-397. doi: 10.2147/CIA.S117637. eCollection 2017.

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Fujino T, Yamada T, Asada T, Tsuboi Y, Wakana C, Mawatari S, Kono S.

EBioMedicine. 2017 Mar;17:199-205. doi: 10.1016/j.ebiom.2017.02.012. Epub 2017 Feb 24.

Regional Cerebral Blood Flow SPECT and MRI in Logopenic Variant Primary Progressive Aphasia

Katsanos AH, Tsiouris S, Sioka C, Zikou A, Fotopoulos A.

Clin Nucl Med. 2017 May;42(5):e277-e280. doi: 10.1097/RLU.0000000000001627.

Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial

Beishuizen CRL, Coley N, Moll van Charante EP, van Gool WA, Richard E, Andrieu S.

J Am Geriatr Soc. 2017 Jul;65(7):1505-1513. doi: 10.1111/jgs.14834. Epub 2017 Mar 6.

MACE versus MoCA: equivalence or superiority? Pragmatic diagnostic test accuracy study

Larner AJ.

Int Psychogeriatr. 2017 Jun;29(6):931-937. doi: 10.1017/S1041610216002210. Epub 2017 Mar 7.

Fractional anisotropy derived from the diffusion tensor distribution function boosts power to detect Alzheimer's disease deficits

Nir TM, Jahanshad N, Villalon-Reina JE, Isaev D, Zavaliangos-Petropulu A, Zhan L, Leow AD, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Diseaase Neuroimaginng Initiative (ADNI).

Magn Reson Med. 2017 Dec;78(6):2322-2333. doi: 10.1002/mrm.26623. Epub 2017 Mar 7.

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.

J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias